Ming Zhang

机构：Hunan Institute of Science and Technology, Suzhou Municipal Hospital, Hunan Vocational Institute of Technology, State Key Laboratory of Respiratory Disease, Shandong Maternal and Child Health Hospital, Nanjing Medical University, Guangzhou Medical University · ORCID：0000-0002-8621-9649

发表论文 74 篇 · 总被引 1578 次 · h-index 23

代表论文

• Oridonin attenuates atherosclerosis by inhibiting foam macrophage formation and inflammation through FABP4/PPARγ signalling (2023 · Journal of Cellular and Molecular Medicine · 被引 37)
• Naringenin Induces HepG2 Cell Apoptosis via ROS-Mediated JAK-2/STAT-3 Signaling Pathways (2023 · Molecules · 被引 30)
• Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles (2022 · Materials Today Bio · 被引 28)
• Machine learning advances the integration of covariates in population pharmacokinetic models: Valproic acid as an example (2022 · Frontiers in Pharmacology · 被引 22)
• NSUN2-Mediated m5C Methylation Impairs Endometrial Receptivity (2024 · Laboratory Investigation · 被引 15)
• Emerging applications of single-cell profiling in precision medicine of atherosclerosis (2024 · Journal of Translational Medicine · 被引 14)